NICE Interventional Procedure Guidelines

Guidance

Current evidence on the safety and efficacy of circular stapled haemorrhoidopexy appears adequate to support the use of the procedure, provided that normal arrangements are in place for consent, audit, and clinical governance.

Clinicians wishing to learn circular stapled haemorrhoidopexy should be trained, mentored, and monitored as described in the Association of Coloproctology’s consensus document on the procedure.

The Procedure.1

Indications

Circular stapled haemorroidopexy is used to treat internal haemorrhoids, which develop when cushions of vascular tissue in the anus undergo pathological change. Haemorrhoids may prolapse and cause bleeding, faecal soiling, itching, and occasionally pain.

Outline of the procedure

In circular stapled rectal haemorrhoidopexy, a stapler is used to excise an annulus of rectal mucosa above the haemorrhoids. This reduces the size of internal haemorrhoids by interrupting their blood supply, and reducing the available rectal mucosa with the potential to prolapse. By contrast, conventional surgical haemorrhoidectomy involves excision of haemorrhoidal tissue, anoderm, and perianal skin.

Efficacy

The studies suggested that patients had less pain and returned to normal activity more quickly after stapled haemorroidopexy than after conventional haemorrhoidectomy. In one randomised controlled trial with 84 patients, the average time of return to work was 6 days after the circular stapled technique, compared with 15 days after conventional surgery. For more details refer to the sources of evidence below.

The Specialist Advisors stated that circular stapled haemorroidopexy was relatively new, but that an increasing number of surgeons were using this approach. The Advisors considered stapled haemorroidopexy to be as effective as the surgical alternative. They noted that there were limited long-term data, and that the durability of the procedure was therefore unclear.

Safety

The studies suggested a lower overall postoperative complication rate with circular stapled haemorroidopexy than with conventional haemorrhoidectomy. A systematic review published in 2001 indicated a significant reduction in the risk of bleeding during the first 2 weeks after the procedure. For more details refer to the sources of evidence below.

The Association of Coloproctology’s consensus document stated that adverse events were related to the possibility of a full thickness excision to the rectal wall, with the potential for injury to the internal anal sphincter. In addition, stretching of the anal sphincter by the stapler head may, in theory, cause injury.

The Specialist Advisors suggested that most of the safety concerns were theoretical, and that many of these were not supported by the trials that have been published.



* Disclaimer:

Please note we are not in a position to diagnose or prescribe for specific medical conditions on our Helpline. Should you have any queries relating to your particular condition we recommend that you consult your GP.

Reference

  1. Interventional procedure overview of circular stapled haemorrhoidectomy accessed on 25/06/08 - http://www.nice.org.uk/nicemedia/pdf/ip/106overview.pdf

Physician Resources

Download pamphlets or view websites for more piles
tools and information.

Go


Patient Materials

Download educational pamphlets and resources for your patients.

Go


Physician Guidelines

Download NICE Interventional Procedure Guidance.

Go



Call the PPH Helpline

0800 028 2231

Speak to a trained nurse about your PPH questions in complete confidence.*




Ethicon Logo

Transforming Patient Care Through Innovation™

This site is published by Ethicon Endo-Surgery, a division of Johnson & Johnson Medical Limited, which is solely responsible for its content. This site is written for a UK audience. Last updated June 2008.

All contents copyright © Ethicon Endo-Surgery, a division of Johnson & Johnson Medical Limited, 1998-2010.

Johnson & Johnson Medical Limited, Po Box 1988, Kirkton Campus, Livingston, West Lothian, EH54 0AB. Registered in Scotland, No SC 132162.